Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

480 public trials 127 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Active, Not Recruiting

Avatrombopag vs. Placebo for CIT in GI Malignancies

NCT05772546

Conditions
Chemotherapy-Induced Thrombocytopenia, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Oregon Health and Science University Hospital Portland, Oregon, United States
  • University of Washington Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors

NCT04336241

Conditions
Breast Diseases, Breast Neoplasms, Cancer, +25 more
Locations
  • Hospital Universitario d'Hebron Barcelona, Spain
  • Hospital Universitario HM Sanchinarro Madrid, Spain
  • Hospital Clinico de Valencia Valencia, Spain
  • The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Merseyside, United Kingdom
View Trial Details
Active, Not Recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +46 more
Locations
  • Arizona Cancer Center at the Unvieristy of Arizona Tucson, Arizona, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Monument Health Cancer Care Institute Rapid City, South Dakota, United States
View Trial Details
Active, Not Recruiting

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

NCT04005339

Conditions
Advanced Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
Locations
  • Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States
  • Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Washington University School of Medicine- Siteman Cancer Center St Louis, Missouri, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Active, Not Recruiting

Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer

NCT04592913

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophagogastric Junction, +4 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Sylmar, California, United States
View all 156 locations
View Trial Details
Active, Not Recruiting

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

NCT04180371

Conditions
Adnexal Diseases, Advanced Solid Tumor Historically Known for High EphA2 Expression, Breast Diseases, +49 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. Encinitas, California, United States
  • University of California - Irvine Medical Center Orange, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 28 locations
View Trial Details

Related conditions